Role of transforming growth factor-β in the progression of heart failure

被引:144
作者
Lim, H.
Zhu, Y. Z.
机构
[1] Natl Univ Singapore, Fac Med, Dept Pharmacol, Singapore 119260, Singapore
[2] Methodist Univ Indonesia, Fac Med, Dept Pharmacol, Medan, Indonesia
[3] Fudan Univ, Sch Pharm, Shanghai 200032, Peoples R China
[4] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China
关键词
transforming growth factor-beta; signaling pathways; heart tissues; therapeutic options;
D O I
10.1007/s00018-006-6085-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor (TGF-beta) is a multifunctional peptide growth factor that has an important role in the regulation of cell growth, differentiation, and repair in a variety of tissues. In mammals, the cytokine has three isoforms, TGF-beta 1, TGF-beta 2, and TGF-beta 3. TGF-beta 1 is up-regulated by Ang II and induction of TGF-beta 1 causes cardiac fibrosis. The stimulus that triggers the expression of TGF-beta 1 may be repeated causing continual injury, which is associated with an increase in the activity of Ang II in heart tissue. The interplay between Ang II and TGF-beta 1 causes continued activation that may result in chronic hypertension and progressive myocardial fibrosis, leading to heart failure. The regulation of TGF-beta 1 secretion and action involves complex transcriptional events. Overproduction of TGF-beta 1 underlies tissue fibrosis. Understanding the actions and signaling transduction of TGF-beta could lead to the development of therapeutic options that may be effective in inhibiting myocardial fibrosis triggered by TGF-beta 1 in heart failure.
引用
收藏
页码:2584 / 2596
页数:13
相关论文
共 147 条
[1]   Tumor necrosis factor α suppresses the induction of connective tissue growth factor by transforming growth factor-β in normal and scleroderma fibroblasts [J].
Abraham, DJ ;
Xu, SW ;
Black, CM ;
Sa, S ;
Xu, YL ;
Leask, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :15220-15225
[2]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[3]   Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis [J].
Azuma, A ;
Nukiwa, T ;
Tsuboi, E ;
Suga, M ;
Abe, S ;
Nakata, K ;
Taguchi, Y ;
Nagai, S ;
Itoh, H ;
Ohi, M ;
Sato, A ;
Kudoh, S ;
Raghu, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (09) :1040-1047
[4]  
Barton D E, 1988, Oncogene Res, V3, P323
[5]  
Bartram U, 2001, CIRCULATION, V103, P2745
[6]   The role of transforming growth factor β in lung development and disease [J].
Bartram, U ;
Speer, CP .
CHEST, 2004, 125 (02) :754-765
[7]  
BHAMBI B, 1991, AM J PATHOL, V139, P1131
[8]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[9]   TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7
[10]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286